Deep Tech Startups
5,883 companies tagged Deep Tech, with their investors and founders.
Prometheus Fuels develops systems that convert intermittent renewable energy into liquid fuels for remote electrification. The ULDES and Fuel Forge systems operate independently from the grid, storing energy as liquid fuels when renewable power is available.
6 investors
Proteus Space designs custom spacecraft buses tailored to individual payload requirements using generative design and flight-proven components, eliminating the compromises of standardized bus solutions.
6 investors
PulseMedica develops femtosecond laser technology for imaging and treating vitreoretinal eye conditions, building medical devices aimed at improving care for patients with retinal diseases. The company operates in the ophthalmic medical device sector.
6 investors
Quaise Energy develops superhot geothermal drilling technology using millimeter-wave powered drilling to access deep geothermal energy sources at unprecedented depths and temperatures for large-scale clean power generation globally.
6 investors
Quantum Motion develops utility-scale quantum computers using silicon spin-qubit architecture compatible with standard semiconductor manufacturing processes and existing foundry supply chains. Its platform is designed to fit into data centres and enable scientific work in fields such as chemistry, medicine, and artificial intelligence.
6 investors
Quartzy provides a platform for lab management and research resource optimization, serving life scientists, lab managers, and academic institutions. The company helps manage orders, inventory, and workflows for laboratory research operations.
6 investors
QurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms. The company was founded by neuroscientists from Harvard to translate emerging discoveries about disease pathways into treatment breakthroughs for ALS patients.
6 investors
Reach develops wireless power beaming technology using AI-driven adaptive systems to transmit electricity over distance to devices and systems, similar to how Wi-Fi transmits data. The company serves applications including drones, autonomous systems, sensors, electric vehicles, and industrial equipment across defense, public safety, and critical infrastructure sectors.
6 investors
Red 6 develops augmented reality flight training technology for military aviators, enabling pilots and autonomous systems to train together in simulated threat environments. Its focus is on defense and military flight training applications.
6 investors
Renaissance Fusion builds stellarators—magnetic-confinement fusion machines—using High Temperature Superconducting (HTS) magnets and liquid metal shields to enable clean energy generation. It is a continental European fusion startup working to industrialize its core technologies for real-world energy grid deployment.
6 investors
Scout Space develops technologies for real-time sensing, data processing, and autonomous systems to protect space infrastructure. The company serves space operators and addresses safety and operational challenges in the space economy.
6 investors
Sepion develops advanced polymer separator technology for batteries and other applications including water separation and materials recovery. The company commercializes research from Berkeley Lab with manufacturing and production capabilities in Silicon Valley.
6 investors
SiFive develops processor IP based on the open-standard RISC-V instruction set architecture, offering customizable and scalable chip designs. It serves semiconductor and hardware developers building processors across a range of applications.
6 investors
Sofar operates an ocean monitoring network and analytics platform serving maritime shipping companies and marine researchers. The company operates Spotter, a network of ocean sensors for data collection, and Wayfinder, a voyage optimization platform that helps shipping companies reduce fuel consumption and emissions by 4-9%.
6 investors
SKY-I is a platform that aggregates fragmented space environmental data into a single system, offering 3D mapping of orbital conditions, satellite positions, and environmental hazards from VLEO to cislunar space. It provides satellite operators and mission engineers with environmental intelligence, anomaly tracking, and API integration to speed up mission planning and reduce mission risk.
6 investors
SpliceBio develops genetic medicines using a proprietary protein splicing platform to treat diseases caused by mutations in large genes. The company is currently in clinical stages, with its lead program targeting Stargardt Disease.
6 investors
Stanhope AI develops agentic AI software based on Active Inference and world models, enabling robots and embodied platforms to make autonomous decisions—including in situations with no training data. Its models run on-device at the edge with low power and cost, integrate with computer vision stacks, and produce explainable, interpretable outputs.
6 investors
Superb AI provides an industrial AI stack for vision and analytics applications across mobility, security, defense, logistics, and manufacturing. The platform integrates data labeling, foundation models, and video analytics for real-world operating conditions.
6 investors
Switch Therapeutics develops RNA interference (RNAi) therapeutic applications targeting central nervous system diseases, leveraging research from Caltech, Harvard Medical School, and City of Hope.
6 investors
Synlogic develops synthetic biology-based biotherapeutics that use engineered living organisms to treat diseases. The company applies synthetic biology approaches to design programmable therapeutic candidates for patients.
6 investors
Syntax Bio develops a discovery platform that accelerates stem cell-derived therapies by using its proprietary Cellgorithm technology to control and direct cell differentiation. The platform enables biopharma companies to speed up cell therapy development, reduce manufacturing costs, and expand their pipeline of potential treatments.
6 investors
Talus develops a proprietary platform that measures and modulates the regulome—the body's gene expression control system—in native cellular contexts. The company designs AI-driven compounds and uses functional proteomics to enable drug discovery for transcription factors and regulatory proteins implicated in oncology, rare disease, and immune dysfunction.
6 investors
Turbine develops computational simulations of cells to accelerate drug discovery and development in oncology, using in silico predictions validated through wet lab experiments.
6 investors
Company working on fully autonomous driving technology, presenting itself under the slogan "We Overtake Tesla." The page is a recruitment section seeking team members to work on self-driving vehicle development.
6 investors